Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Accumulated Expenses (2016 - 2025)

Traws Pharma (TRAW) has disclosed Other Accumulated Expenses for 9 consecutive years, with $128000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $128000.0; the TTM value through Dec 2025 reached $128000.0, changed N/A, while the annual FY2025 figure was $128000.0, N/A changed from the prior year.
  • Other Accumulated Expenses hit $128000.0 in Q4 2025 for Traws Pharma, up from $14000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $128000.0 in Q4 2025 and bottomed at $128000.0 in Q4 2025.